These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Magnetic nanoparticle assisted molecular MR imaging. Jun YW; Jang JT; Cheon J Adv Exp Med Biol; 2007; 620():85-106. PubMed ID: 18217337 [TBL] [Abstract][Full Text] [Related]
27. Liposome-based probes for molecular imaging: from basic research to the bedside. Xia Y; Xu C; Zhang X; Ning P; Wang Z; Tian J; Chen X Nanoscale; 2019 Mar; 11(13):5822-5838. PubMed ID: 30888379 [TBL] [Abstract][Full Text] [Related]
29. PET-MRI fusion in head-and-neck oncology: current status and implications for hybrid PET/MRI. Loeffelbein DJ; Souvatzoglou M; Wankerl V; Martinez-Möller A; Dinges J; Schwaiger M; Beer AJ J Oral Maxillofac Surg; 2012 Feb; 70(2):473-83. PubMed ID: 21601338 [TBL] [Abstract][Full Text] [Related]
30. Rationale for the combination of nuclear medicine with magnetic resonance for pre-clinical imaging. Wagenaar DJ; Kapusta M; Li J; Patt BE Technol Cancer Res Treat; 2006 Aug; 5(4):343-50. PubMed ID: 16866565 [TBL] [Abstract][Full Text] [Related]
31. An overview of responsive MRI contrast agents for molecular imaging. Yoo B; Pagel MD Front Biosci; 2008 Jan; 13():1733-52. PubMed ID: 17981664 [TBL] [Abstract][Full Text] [Related]
32. New perspectives on bone marrow contrast agents and molecular imaging. Daldrup-Link HE; Mohanty A; Cuenod C; Pichler B; Link T Semin Musculoskelet Radiol; 2009 Jun; 13(2):145-56. PubMed ID: 19455477 [TBL] [Abstract][Full Text] [Related]
33. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents. Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343 [TBL] [Abstract][Full Text] [Related]
34. Multimodal liposomes for SPECT/MR imaging as a tool for in situ relaxivity measurements. de Vries A; Kok MB; Sanders HM; Nicolay K; Strijkers GJ; Grüll H Contrast Media Mol Imaging; 2012; 7(1):68-75. PubMed ID: 22344882 [TBL] [Abstract][Full Text] [Related]
35. Strategies for sensing neurotransmitters with responsive MRI contrast agents. Angelovski G; Tóth É Chem Soc Rev; 2017 Jan; 46(2):324-336. PubMed ID: 28059423 [TBL] [Abstract][Full Text] [Related]
36. Liposomes for PET and MR Imaging and for Dual Targeting (Magnetic Field/Glucose Moiety): Synthesis, Properties, and in Vivo Studies. Malinge J; Géraudie B; Savel P; Nataf V; Prignon A; Provost C; Zhang Y; Ou P; Kerrou K; Talbot JN; Siaugue JM; Sollogoub M; Ménager C Mol Pharm; 2017 Feb; 14(2):406-414. PubMed ID: 28029258 [TBL] [Abstract][Full Text] [Related]
37. [Contrast media for magnetic resonance tomographic lymph node diagnosis (MR lymphography)]. Taupitz M; Wagner S; Hamm B Radiologe; 1996 Feb; 36(2):134-40. PubMed ID: 8867430 [TBL] [Abstract][Full Text] [Related]
38. Molecular imaging: challenges of bringing imaging of intracellular targets into common clinical use. Skotland T Contrast Media Mol Imaging; 2012; 7(1):1-6. PubMed ID: 22344874 [TBL] [Abstract][Full Text] [Related]
39. Controlling RNA Expression in Cancer Using Iron Oxide Nanoparticles Detectable by MRI and In Vivo Optical Imaging. Medarova Z; Balcioglu M; Yigit MV Methods Mol Biol; 2016; 1372():163-79. PubMed ID: 26530923 [TBL] [Abstract][Full Text] [Related]
40. A Polypeptide-Based, Membrane-Penetrating, Target-Specific Contrast Agent for Magnetic Resonance Molecular Imaging. Yu K; Yu Y; Yao Y; Wu Z; Fu S; Cheng RH; Chen YW; Chen HY; Zhou J; Hwang DW; Ding S ACS Appl Bio Mater; 2021 Feb; 4(2):1597-1604. PubMed ID: 35014508 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]